NextCell Pharma

Dr Davies, in addition to her role at NextCell, is a member of the scientific advisory board for the European Tissue Repair Society (ETRS). ETRS and EWMA have partnered for a session at the annual conference, that brings together wound management researchers, clinicians and industrial partners to discuss innovative therapies and treatment options for wound patients.

Dr Davies has been invited to speak at the conference on 4^th May. Her presentation is entitled, "Mesenchymal stromal cells - a novel approach to the treatment of type 1 diabetes". The meeting will be held at MICo Milano Convention Centre, Milan, Italy, from Wednesday 3^rd to Friday 5^th of May.